JosephJamesJenningsMD

PubMed

• 144 citations
  Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center study.
  Hamzah Abu-Sbeih, Faisal Ali, Dana Alsaadi, Joseph Jennings, Wenyi Luo
  Journal for Immunotherapy of Cancer. 2018-12-05
• 26 citations
  NAFLD-NASH: An Under-Recognized Epidemic.
  Joseph Jennings, Charles Faselis, Michael D Yao
  Current Vascular Pharmacology. 2017-06-20
• 64 citations
  Hepatotoxicity induced by immune checkpoint inhibitors: a comprehensive review including current and alternative management strategies.
  Joseph Jennings, Rohan Mandaliya, Ahmad Nakshabandi, James H. Lewis
  Expert Opinion on Drug Metabolism & Toxicology. 2019-02-05

Abstracts/Posters

• Safety and Efficacy of EUS-guided Fiducial Placement in Patients with Pancreatic Cancer
  Joseph Jennings, MD; Samuel Kallus, MD; Walid Chalhoub, MD; Nadim Haddad, MD, ResidentResearch Symposium, Georgetown University Hospital, 5/2014
• Atypical Post Myocardial Infarction Ventricular Tachycardia
  Joseph Jennings, MD; Brent Finklea, MD, Hospital Medicine 2014, Las Vegas, Nevada, 3/27/2014
• Lymphomas Associated with Biological Therapy for Inflammatory Bowel Disease
  Joseph Jennings, MD; Farah Monzur, MD; Mark Mattar, MD; Aline Charabaty, MD, American College of Gastroenterology Annual Meeting 2013, San Diego, CA
• New Onset of Seizures and Acute Renal Failure following Synthetic Cannabinoid Use
  Joseph Jennings, MD; Adam Brown, MD; Kevin Motz, BS, Georgetown University Hospital Internal Medicine Research Day, Georgetown University Hospital - Washington, DC, 5/2013
• Timing the Occurrence of Colorectal Cancer in Patients with Inflammatory Bowel Disease of Varying Severity at a Tertiary Care Center
  Farah Monzur, MD; Joseph Jennings, MD; Mark Mattar, MD; Aline Charabaty, MD, American College of Gastroenterology Annual Meeting 2013, San Diego, CA
• Join now to see all

Lectures

• Help! My ACLS Algorithm isn't Working! 
  Georgetown University Hospital - Washington, DC - 6/2014
• Lymphomas Associated with Biological and Immunomodulator Therapy in Patients with Inflammatory Bowel Disease 
  Providence Hospital - Washington, DC - 5/2013